Selected research
Industry Research
Amlodipine Besylate Industry Research Report 2026
Market perspective
The global Amlodipine Besylate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amlodipine Besylate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amlodipine Besylate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amlodipine Besylate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amlodipine Besylate include Alkem Laboratories, Apotex, Aurobindo Pharma, Cipla, CR Pharmaceutical, Dr. Reddy's Laboratories, Epic Pharma, Hikma Pharmaceuticals and InvaGen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amlodipine Besylate market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amlodipine Besylate Market by Company
Alkem Laboratories
Apotex
Aurobindo Pharma
Cipla
CR Pharmaceutical
Dr. Reddy's Laboratories
Epic Pharma
Hikma Pharmaceuticals
InvaGen Pharmaceuticals
Lupin Pharmaceuticals
MACLEODS
Oxford Pharm
Strides Pharma
Teva Pharmaceutical
Upsher-Smith Laboratories
Wockhardt
Zydus Pharmaceuticals
Pfizer
Mylan
Sun Pharmaceutical
Amlodipine Besylate Segment by Type
10mg Tablets
2.5mg Tablets
5mg Tablets
Amlodipine Besylate Segment by Application
High Blood Pressure
Heart Disease
Amlodipine Besylate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amlodipine Besylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amlodipine Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg Tablets
- 2.5mg Tablets
- 5mg Tablets
Applications
- High Blood Pressure
- Heart Disease
Companies covered
- Alkem Laboratories
- Apotex
- Aurobindo Pharma
- Cipla
- CR Pharmaceutical
- Dr. Reddy's Laboratories
- Epic Pharma
- Hikma Pharmaceuticals
- InvaGen Pharmaceuticals
- Lupin Pharmaceuticals
- MACLEODS
- Oxford Pharm
- Strides Pharma
- Teva Pharmaceutical
- Upsher-Smith Laboratories
- Wockhardt
- Zydus Pharmaceuticals
- Pfizer
- Mylan
- Sun Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amlodipine Besylate Market Size (2021-2032)
- 2.2.2 Global Amlodipine Besylate Sales (2021-2032)
- 2.2.3 Global Amlodipine Besylate Market Average Price (2021-2032)
- 2.3 Amlodipine Besylate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg Tablets
- 2.3.3 2.5mg Tablets
- 2.3.4 5mg Tablets
- 2.4 Amlodipine Besylate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 High Blood Pressure
- 2.4.3 Heart Disease
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amlodipine Besylate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amlodipine Besylate Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Amlodipine Besylate Revenue of Manufacturers (2021-2026)
- 3.4 Global Amlodipine Besylate Average Price by Manufacturers (2021-2026)
- 3.5 Global Amlodipine Besylate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amlodipine Besylate, Product Type & Application
- 3.8 Global Manufacturers of Amlodipine Besylate, Established Date
- 3.9 Global Amlodipine Besylate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alkem Laboratories
- 4.1.1 Alkem Laboratories Company Information
- 4.1.2 Alkem Laboratories Business Overview
- 4.1.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
- 4.1.5 Alkem Laboratories Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Amlodipine Besylate Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 Aurobindo Pharma
- 4.3.1 Aurobindo Pharma Company Information
- 4.3.2 Aurobindo Pharma Business Overview
- 4.3.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
- 4.3.5 Aurobindo Pharma Recent Developments
- 4.4 Cipla
- 4.4.1 Cipla Company Information
- 4.4.2 Cipla Business Overview
- 4.4.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cipla Amlodipine Besylate Product Portfolio
- 4.4.5 Cipla Recent Developments
- 4.5 CR Pharmaceutical
- 4.5.1 CR Pharmaceutical Company Information
- 4.5.2 CR Pharmaceutical Business Overview
- 4.5.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
- 4.5.5 CR Pharmaceutical Recent Developments
- 4.6 Dr. Reddy's Laboratories
- 4.6.1 Dr. Reddy's Laboratories Company Information
- 4.6.2 Dr. Reddy's Laboratories Business Overview
- 4.6.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
- 4.6.5 Dr. Reddy's Laboratories Recent Developments
- 4.7 Epic Pharma
- 4.7.1 Epic Pharma Company Information
- 4.7.2 Epic Pharma Business Overview
- 4.7.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Epic Pharma Amlodipine Besylate Product Portfolio
- 4.7.5 Epic Pharma Recent Developments
- 4.8 Hikma Pharmaceuticals
- 4.8.1 Hikma Pharmaceuticals Company Information
- 4.8.2 Hikma Pharmaceuticals Business Overview
- 4.8.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
- 4.8.5 Hikma Pharmaceuticals Recent Developments
- 4.9 InvaGen Pharmaceuticals
- 4.9.1 InvaGen Pharmaceuticals Company Information
- 4.9.2 InvaGen Pharmaceuticals Business Overview
- 4.9.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
- 4.9.5 InvaGen Pharmaceuticals Recent Developments
- 4.10 Lupin Pharmaceuticals
- 4.10.1 Lupin Pharmaceuticals Company Information
- 4.10.2 Lupin Pharmaceuticals Business Overview
- 4.10.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
- 4.10.5 Lupin Pharmaceuticals Recent Developments
- 4.11 MACLEODS
- 4.11.1 MACLEODS Company Information
- 4.11.2 MACLEODS Business Overview
- 4.11.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 MACLEODS Amlodipine Besylate Product Portfolio
- 4.11.5 MACLEODS Recent Developments
- 4.12 Oxford Pharm
- 4.12.1 Oxford Pharm Company Information
- 4.12.2 Oxford Pharm Business Overview
- 4.12.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Oxford Pharm Amlodipine Besylate Product Portfolio
- 4.12.5 Oxford Pharm Recent Developments
- 4.13 Strides Pharma
- 4.13.1 Strides Pharma Company Information
- 4.13.2 Strides Pharma Business Overview
- 4.13.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Strides Pharma Amlodipine Besylate Product Portfolio
- 4.13.5 Strides Pharma Recent Developments
- 4.14 Teva Pharmaceutical
- 4.14.1 Teva Pharmaceutical Company Information
- 4.14.2 Teva Pharmaceutical Business Overview
- 4.14.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
- 4.14.5 Teva Pharmaceutical Recent Developments
- 4.15 Upsher-Smith Laboratories
- 4.15.1 Upsher-Smith Laboratories Company Information
- 4.15.2 Upsher-Smith Laboratories Business Overview
- 4.15.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
- 4.15.5 Upsher-Smith Laboratories Recent Developments
- 4.16 Wockhardt
- 4.16.1 Wockhardt Company Information
- 4.16.2 Wockhardt Business Overview
- 4.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Wockhardt Amlodipine Besylate Product Portfolio
- 4.16.5 Wockhardt Recent Developments
- 4.17 Zydus Pharmaceuticals
- 4.17.1 Zydus Pharmaceuticals Company Information
- 4.17.2 Zydus Pharmaceuticals Business Overview
- 4.17.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
- 4.17.5 Zydus Pharmaceuticals Recent Developments
- 4.18 Pfizer
- 4.18.1 Pfizer Company Information
- 4.18.2 Pfizer Business Overview
- 4.18.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Pfizer Amlodipine Besylate Product Portfolio
- 4.18.5 Pfizer Recent Developments
- 4.19 Mylan
- 4.19.1 Mylan Company Information
- 4.19.2 Mylan Business Overview
- 4.19.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Mylan Amlodipine Besylate Product Portfolio
- 4.19.5 Mylan Recent Developments
- 4.20 Sun Pharmaceutical
- 4.20.1 Sun Pharmaceutical Company Information
- 4.20.2 Sun Pharmaceutical Business Overview
- 4.20.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
- 4.20.5 Sun Pharmaceutical Recent Developments
5 Global Amlodipine Besylate Market Scenario by Region
- 5.1 Global Amlodipine Besylate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amlodipine Besylate Sales by Region: 2021-2032
- 5.2.1 Global Amlodipine Besylate Sales by Region: 2021-2026
- 5.2.2 Global Amlodipine Besylate Sales by Region: 2027-2032
- 5.3 Global Amlodipine Besylate Revenue by Region: 2021-2032
- 5.3.1 Global Amlodipine Besylate Revenue by Region: 2021-2026
- 5.3.2 Global Amlodipine Besylate Revenue by Region: 2027-2032
- 5.4 North America Amlodipine Besylate Market Facts & Figures by Country
- 5.4.1 North America Amlodipine Besylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amlodipine Besylate Sales by Country (2021-2032)
- 5.4.3 North America Amlodipine Besylate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Amlodipine Besylate Market Facts & Figures by Country
- 5.5.1 Europe Amlodipine Besylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amlodipine Besylate Sales by Country (2021-2032)
- 5.5.3 Europe Amlodipine Besylate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amlodipine Besylate Market Facts & Figures by Country
- 5.7.1 South America Amlodipine Besylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amlodipine Besylate Sales by Country (2021-2032)
- 5.7.3 South America Amlodipine Besylate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Amlodipine Besylate Sales by Type (2021-2032)
- 6.1.1 Global Amlodipine Besylate Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Amlodipine Besylate Sales Market Share by Type (2021-2032)
- 6.2 Global Amlodipine Besylate Revenue by Type (2021-2032)
- 6.2.1 Global Amlodipine Besylate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amlodipine Besylate Revenue Market Share by Type (2021-2032)
- 6.3 Global Amlodipine Besylate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amlodipine Besylate Sales by Application (2021-2032)
- 7.1.1 Global Amlodipine Besylate Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Amlodipine Besylate Sales Market Share by Application (2021-2032)
- 7.2 Global Amlodipine Besylate Revenue by Application (2021-2032)
- 7.2.1 Global Amlodipine Besylate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amlodipine Besylate Revenue Market Share by Application (2021-2032)
- 7.3 Global Amlodipine Besylate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amlodipine Besylate Value Chain Analysis
- 8.1.1 Amlodipine Besylate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amlodipine Besylate Production Mode & Process
- 8.2 Amlodipine Besylate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amlodipine Besylate Distributors
- 8.2.3 Amlodipine Besylate Customers
9 Global Amlodipine Besylate Analyzing Market Dynamics
- 9.1 Amlodipine Besylate Industry Trends
- 9.2 Amlodipine Besylate Industry Drivers
- 9.3 Amlodipine Besylate Industry Opportunities and Challenges
- 9.4 Amlodipine Besylate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst